Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: Model of aging and neurodegenerative disease

Journal of Neuroscience

Volumn 18, Issue 15, 1998, Pages 5614-5629

  Ho, Angela ^a   Blum, Mariann ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Compensatory sprouting; Dopaminergic neurons; Growth factors; IL 1; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; INTERLEUKIN 1; NEUROTOXIN;

AGING; AMINO ACID SYNTHESIS; ANIMAL CELL; ARTICLE; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; IMMUNE RESPONSE; IMMUNOREACTIVITY; MOUSE; NERVE CELL PLASTICITY; NERVE ENDING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0032145369     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-15-05614.1998     Document Type: Article

References (25)

1. Agid Y, Javoy-Agid F, Ruberg M (1987) Biochemistry of neurotransmitters in Parkinson's disease. Mov Disord 2:166-230.
2. Akaneya Y, Takahashi M, Hatanaka H (1995) Interleukin-1β enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp Neurol 136:44-52.
3. Araujo D, Cotman C (1992) Basic FGF in astoglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J Neurosci 12:1668-1678.
4. Bankiewicz KS, Plunkett RJ, Kopin IJ, Jacobowitz DM, London WT, Oldfield EH (1988) Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. Prog Brain Res 78:543-549.
5. Bankiewicz KS, Plunkett RJ, Jacobowitz DM, Kopin IJ, Oldfield EH (1991) Sprouting-induced recovery from MPTP-induced parkinsonism in primates after fetal non-dopaminergic brain implants: histochemical and behavioral studies. J Neurosurg 74:97-101.
6. Beller D, Springer T, Schreiber R (1982) Anti-Mac-1 inhibits the mouse and human type three complement receptor. J Exp Med 156:1000-1009.
7. Björklund A, Lindvall O (1984) Dopamine-containing system in the CNS. In: Handbook of chemical neuroanatomy, Vol 2 (Björklund A, Lindvall O, eds), pp 55-111. Amsterdam: Elsevier.
8. Blanchard V, Anglade P, Dziewczapolski G, Savasta M, Raisman-Vozari R (1996) Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra. Brain Res 709:319-325.
9. Bohn MC, Cupit L, Marciano F, Gash DM (1987) Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237:913-916.
10. Breder S, Dinarello C, Laper C (1988) Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240:321-324.
11. Czlonkowska A, Kohutnicka M, Kurkowska-Jastrzebska I, Czlonkowski A (1996) Microglial reaction in M FTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease in mice model. Neurodegeneration 5:137-143.
12. Date I, Felten SY, Felten DL (1989) Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice. Neurosci Lett 106:282-286.
13. Date I, Felten D, Felten S (1990a) Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. Brain Res 519:266-276.
14. Date I, Notter M, Felten S, Felten D (1990b) MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res 526:156-160.
15. Date I, Yoshimoto Y, Takashi I, Yasuyuki M, Futura T, Asari S, Ohmoto T (1994) Effect of host age upon the degree of nigrostriatal dopaminergic system recovery following cografts of adrenal medulla and pretransected peripheral nerve. Brain Res 637:50-56.
16. Eddleston M, Mücke L (1993) Molecular profile of reactive astrocytes-implications for their role in neurological disease. Neuroscience 54:15-36.
17. Ewing SE, Weber RJ, Zauner A, Plunkett RJ (1992) Recovery in hemiparkinsonian rats following intrastriatal implantation of activated leukocytes. Brain Res 576:42-48.
18. Farrar W, Killian P, Ruff M, Hill J, Pert C (1987) Visualization and characterization of interleukin-1 receptors in brain. J Immunol 139:459-463.
19. Fiandaca MS, Kordower JH, Hansen JT, Jiao SS, Gash DM (1988) Adrenal medullary autografts into the basal ganglia of cebus monkeys: injury induced regeneration. Exp Neurol 102:76-91.
20. Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E (1982) Production of prostaglandin E and interleukin-1 like factor by cultured astrocytes and C glioma cells. J Immunol 129:2413-2419.
21. Francis JW, Visger JV, Markelonis GJ, Oh TH (1995) Neuroglial responses to the dopaminergic neurotoxicant l-methyl-4-phenyl1,2,3,6-tetrahydropyridine in mouse striatum. Neurotoxicol Teratol 17:7-12.
22. German D, Manaye D, Smith W, Woodward D, Saper C (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 26:507-514.
23. Gilad G, Reis D (1979) Collateral sprouting in central mesolimbic dopamine neurons: biochemical and immunocytochemical evidence of changes in the activity and distribution of tyrosine hydroxylase in terminal field and in cell bodies of A10 neurons. Brain Res 160:17-36.
24. Giulian D (1987) Ameboid microglia as effectors of inflammation in the central nervous system. J Neurosci Res 18:155-171.
25. Giulian D (1990) Microglia, cytokines, and cytotoxins: modulators of cellular responses after injury to the central nervous system. J Immunol Immunopharmacol 10:15-21.